Triglyceride-rich lipoproteins prevent septic death in rats

doi:10.1084/jem.182.1.267

This Article

	Full Text (PDF, 570K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Read, T. E.
	Articles by Rapp, J. H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Read, T. E.
	Articles by Rapp, J. H.


Social Bookmarking

	What's this?

ARTICLES

Triglyceride-rich lipoproteins prevent septic death in rats

TE Read, C Grunfeld, ZL Kumwenda, MC Calhoun, JP Kane, KR Feingold and JH Rapp
Department of Surgery, University of California, San Francisco 94143, USA.

Triglyceride-rich lipoproteins bind and inactive bacterial endotoxin in vitro and prevent death when given before a lethal dose of endotoxin in animals. However, lipoproteins have not yet been demonstrated to improve survival in polymicrobial gram-negative sepsis. We therefore tested the ability of triglyceride-rich lipoproteins to prevent death after cecal ligation and puncture (CLP) in rats. Animals were given bolus infusions of either chylomicrons (1 g triglyceride/kg per 4 h) or an equal volume of saline for 28 h after CLP. Chylomicron infusions significantly improved survival (measured at 96 h) compared with saline controls (80 vs 27%, P < or = 0.03). Chylomicron infusions also reduced serum levels of endotoxin, measured 90 min (26 +/- 3 vs 136 +/- 51 pg/ml, mean +/- SEM, P < or = 0.03) and 6 h (121 +/- 54 vs 1,026 +/- 459 pg/ml, P < or = 0.05) after CLP. The reduction in serum endotoxin correlated with a reduction in serum tumor necrosis factor, measured 6 h after CLP (0 +/- 0 vs 58 +/- 24 pg/ml, P < or = 0.03), suggesting that chylomicrons improve survival in this model by limiting macrophage exposure to endotoxin and thereby reducing secretion of inflammatory cytokines. Infusions of a synthetic triglyceride-rich lipid emulsion (Intralipid; KabiVitrum, Inc., Alameda, CA) (1 g triglyceride/kg) also significantly improved survival compared with saline controls (71 vs 27%, P < or = 0.03). These data demonstrate that triglyceride-rich lipoproteins can protect animals from lethal polymicrobial gram- negative sepsis.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Grunfeld, C., Feingold, K. R. (2009). Endotoxin in the gut and chylomicrons: translocation or transportation?. J. Lipid Res. 50: 1-2 [Full Text]
Ghoshal, S., Witta, J., Zhong, J., de Villiers, W., Eckhardt, E. (2009). Chylomicrons promote intestinal absorption of lipopolysaccharides. J. Lipid Res. 50: 90-97 [Abstract] [Full Text]
Kattan, O. M., Kasravi, F. B., Elford, E. L., Schell, M. T., Harris, H. W. (2008). Apolipoprotein E-Mediated Immune Regulation in Sepsis. J. Immunol. 181: 1399-1408 [Abstract] [Full Text]
Munford, R. S. (2005). Invited review: Detoxifying endotoxin: time, place and person. Innate Immunity 11: 69-84 [Abstract]
Berbee, J. F.P., Havekes, L. M., Rensen, P. C.N. (2005). Apolipoproteins modulate the inflammatory response to lipopolysaccharide. Innate Immunity 11: 97-103 [Abstract]
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., Grunfeld, C. (2004). Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196 [Abstract] [Full Text]
Sprong, T., Netea, M. G., van der Ley, P., Verver-Jansen, T. J. G., Jacobs, L. E. H., Stalenhoef, A., van der Meer, J. W. M., van Deuren, M. (2004). Human lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitidis LPS, and complete Gram-negative bacteria. J. Lipid Res. 45: 742-749 [Abstract] [Full Text]
Rauchhaus, M., Clark, A. L., Doehner, W., Davos, C., Bolger, A., Sharma, R., Coats, A. J. S., Anker, S. D. (2003). The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 42: 1933-1940 [Abstract] [Full Text]
Lanza-Jacoby, S., Miller, S., Jacob, S., Heumann, D., Minchenko, A. G., Flynn, J. T. (2003). Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice. Innate Immunity 9: 341-347 [Abstract]
Kitchens, R. L., Thompson, P. A., Munford, R. S., O'Keefe, G. E. (2003). Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J. Lipid Res. 44: 2339-2348 [Abstract] [Full Text]
Liu, D., Cai, S., Gu, X., Scafidi, J., Wu, X., Davis, A. E. III (2003). C1 Inhibitor Prevents Endotoxin Shock Via a Direct Interaction with Lipopolysaccharide. J. Immunol. 171: 2594-2601 [Abstract] [Full Text]
Van Amersfoort, E. S., Van Berkel, T. J. C., Kuiper, J. (2003). Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock. Clin. Microbiol. Rev. 16: 379-414 [Abstract] [Full Text]
Kitchens, R. L., Thompson, P. A. (2003). Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins. Innate Immunity 9: 113-118 [Abstract]
Harris, H. W., Gosnell, J. E., Kumwenda, Z. L. (2000). Review: The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. Innate Immunity 6: 421-430 [Abstract]
Kitchens, R. L., Thompson, P. A., O'Keefe, G. E., Munford, R. S. (2000). Plasma constituents regulate LPS binding to, and release from, the monocyte cell surface. Innate Immunity 6: 477-482 [Abstract]
Vesy, C. J., Kitchens, R. L., Wolfbauer, G., Albers, J. J., Munford, R. S. (2000). Lipopolysaccharide-Binding Protein and Phospholipid Transfer Protein Release Lipopolysaccharides from Gram-Negative Bacterial Membranes. Infect. Immun. 68: 2410-2417 [Abstract] [Full Text]
Kitchens, R. L., Wolfbauer, G., Albers, J. J., Munford, R. S. (1999). Plasma Lipoproteins Promote the Release of Bacterial Lipopolysaccharide from the Monocyte Cell Surface. J. Biol. Chem. 274: 34116-34122 [Abstract] [Full Text]
Hill, M. R., Clarke, S., Rodgers, K., Thornhill, B., Peters, J. M., Gonzalez, F. J., Gimble, J. M. (1999). Effect of Peroxisome Proliferator-Activated Receptor Alpha Activators on Tumor Necrosis Factor Expression in Mice during Endotoxemia. Infect. Immun. 67: 3488-3493 [Abstract] [Full Text]
de Bont, N., Netea, M. G., Demacker, P. N. M., Verschueren, I., Kullberg, B. J., van Dijk, K. W., van der Meer, J. W. M., Stalenhoef, A. F. H. (1999). Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J. Lipid Res. 40: 680-685 [Abstract] [Full Text]
Grunfeld, C., Marshall, M., Shigenaga, J. K., Moser, A. H., Tobias, P., Feingold, K. R. (1999). Lipoproteins inhibit macrophage activation by lipoteichoic acid. J. Lipid Res. 40: 245-252 [Abstract] [Full Text]
Netea, M. G., de Bont, N., Demacker, P. N.�M., Kullberg, B. J., Jacobs, L. E.�H., Verver-Jansen, T. J.�G., Stalenhoef, A. F.�H., Van der Meer, J. W.�M. (1998). Lipoprotein(a) Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production by Human Mononuclear Cells. Infect. Immun. 66: 2365-2367 [Abstract] [Full Text]
Netea, M. G., Demacker, P. N.M., Verver-Jansen, T., Jacobs, L., Jan Kullberg, B., Stalenhoef, A. F.H., Van der Meer, J. W.M. (1997). The dense low-density lipoprotein (LDL) subfractions are more potent than buoyant LDL for binding and neutralization of lipopolysaccharide. Innate Immunity 4: 409-413 [Abstract]
Lemaire, L.C.J.M., van der Poll, T., van Lanschot, J.J.B., Levels, H.M., van der Ende, B., van Deventer, S.J.H., Gouma, D.J. (1997). Human thoracic duct lymph inhibits lipopolysaccharide-induced release of cytokines. Innate Immunity 4: 331-338 [Abstract]